TOP > News Release
- 2010.03.12
- Daiichi Sankyo Announces Second Mid-term Business Management Plan (FY 2010-2012)
- 2010.03.05
- Daiichi Sankyo to join the National Cherry Blossom Festival in Washington D.C. to celebrate the 100-year anniversary of the gift of cherry blossom trees from Japan
- 2010.02.26
- Daiichi Sankyo Group to Expand its Business Scope in Japan through Establishment of Daiichi Sankyo Espha Co., Ltd.
- 2010.02.15
- FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)
- 2010.02.10
- Daiichi Sankyo to Launch Innovator Products in Mexico through Ranbaxy
Companies to Fully Leverage the Synergistic Power of the Hybrid Business Model
- 2010.02.08
- Announcement of Approval Application in Japan for Manufacturing and Marketing of SUN Y7017 (Memantine) for the Treatment of Alzheimer's Type Dementia
- 2010.02.03
- DAIICHI SANKYO INITIATES LARGEST SINGLE, DOUBLE-BLIND,RANDOMIZED, PHASE 3 TRIAL FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM
- 2010.02.01
- Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958, a Long-Acting Neuraminidase Inhibitor for the Treatment of Influenza
- 2010.01.20
- Daiichi Sankyo Receives Approval to Manufacture and Market Rezaltas(R) Combination Tablets to Treat Hypertension
- 2010.01.06
- Luitpold Pharmaceuticals Inc. Acquires PharmaForce, Inc., a U.S. Specialty Injectable Pharmaceutical Company
- 2009.12.21
- Daiichi Sankyo to Leverage Ranbaxy's Presence in Africa for Marketing and Distribution Olmesartan to be launched in six African countries
- 2009.12.11
- Results of a Clinical Phase 3 Trial of an Oral Factor Xa Inhibitor, Edoxaban, in Prevention of Post-Operative Venous Thromboembolism
- 2009.11.09
- Regarding the Lawsuit to Revoke the Decision to Nullify a Portion of the Patent Term Extension for Levofloxacin in Japan
- 2009.10.30
- Differences between Consolidated Forecasts and Consolidated Results for the First Six Months of Fiscal Year Ending March 2010
- 2009.10.29
- Daiichi Sankyo Submits Application for Approval of Levofloxacin Hydrate Injection in Japan
- 2009.10.16
- Additional indication for the natural-type interferon beta preparation Feron(R) against "chronic hepatitis C on concomitant use with ribavirin"
- 2009.10.05
- Daiichi Sankyo to Leverage Ranbaxy's Presence in Mexico for Marketing and Distribution
New Division will bring Daiichi Sankyo's innovator products to Mexican market
- 2009.09.01
- Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of EVISTA in Romania
